Products

Sandoo magnum est Ketorolac Trometamolum, Hydrochloridum Olopatadinum, Vancomycin hydrochloridum artifices et praebitores in Sinis. Nostra officina in API, anti-cancro, antivirali medicamento media, subtilia chemicis, cibariis additivis export et plus quam X annos importat, positi sunt, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniae Regnum. Gallia, etc., et paulatim plus XX regionibus circum orbem terrarum tegunt.
View as  
 
(S)-(+)-N-(2,3-Epoxypropyl)Phthalimide

(S)-(+)-N-(2,3-Epoxypropyl)Phthalimide

(S)-(+)-N-(2,3-Epoxypropyl)Phthalimide
Formulae hypotheticae ₠H₉NO₃
Exustio Point:101-103°C
Molecular pondus:203.19
CAS NO:161596-47-0
Usu: Rivaroxaban Intermediates​

Lege plusMitte Inquisitionem
4-(4-Aminophenyl) Morpholin-3-One

4-(4-Aminophenyl) Morpholin-3-One

4-(4-Aminophenyl) Morpholin-3-One
CAS NO:438056-69-0
Formulae hypotheticae: Câ‚ â‚€Hâ‚ â‚‚Nâ‚‚Oâ‚‚
Molecular Weight:192.21
Usu: Rivaroxaban Intermediates​

Lege plusMitte Inquisitionem
(R) -3-(Boc-Amino) Piperidine

(R) -3-(Boc-Amino) Piperidine

(R) -3-(Boc-Amino) Piperidine
CAS NO:309956-78-3
Formulae hypotheticae: Câ‚ â‚€Hâ‚‚â‚€Nâ‚‚Oâ‚‚
Pondus hypotheticum: 200.28
Usus: Linagliptin intermedia

Lege plusMitte Inquisitionem
2-(Chloromethyl) -4-Methylquinazoline

2-(Chloromethyl) -4-Methylquinazoline

2-(Chloromethyl) -4-Methylquinazoline
CAS NO:109113-72-6
Formulae hypotheticae: C₠₀H₉ClN₂
Pondus hypotheticum: 192.64
Usus: Linagliptin Intermediates​

Lege plusMitte Inquisitionem
3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine

3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine

3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine
CAS NO:666816-98-4
Forma hypothetica: C10H9BrN4O2
Mol. Pondus: 297.11
Usus: Linagliptin Intermediates​

Lege plusMitte Inquisitionem
8-Bromo-3-Methyl-Xanthine

8-Bromo-3-Methyl-Xanthine

8-Bromo-3-Methyl-Xanthine
CAS NO:​93703-24-3
Formula hypothetica: C₆Hâ‚…BrNâ"Oâ‚‚
Molecular Weight:245.03
Usus: Linagliptin intermedia

Lege plusMitte Inquisitionem
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept